JP2021508728A5 - - Google Patents
Info
- Publication number
- JP2021508728A5 JP2021508728A5 JP2020536766A JP2020536766A JP2021508728A5 JP 2021508728 A5 JP2021508728 A5 JP 2021508728A5 JP 2020536766 A JP2020536766 A JP 2020536766A JP 2020536766 A JP2020536766 A JP 2020536766A JP 2021508728 A5 JP2021508728 A5 JP 2021508728A5
- Authority
- JP
- Japan
- Prior art keywords
- injectable composition
- composition according
- compound represented
- formula
- vesicles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023187032A JP2024012452A (ja) | 2018-01-02 | 2023-10-31 | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
| JP2025060460A JP2025106349A (ja) | 2018-01-02 | 2025-04-01 | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862612893P | 2018-01-02 | 2018-01-02 | |
| US62/612,893 | 2018-01-02 | ||
| PCT/US2018/067216 WO2019135954A1 (en) | 2018-01-02 | 2018-12-21 | Injectable compositions of triterpenoid antifungals encapsulated in liposomes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023187032A Division JP2024012452A (ja) | 2018-01-02 | 2023-10-31 | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021508728A JP2021508728A (ja) | 2021-03-11 |
| JP2021508728A5 true JP2021508728A5 (cg-RX-API-DMAC7.html) | 2022-03-24 |
| JP7378401B2 JP7378401B2 (ja) | 2023-11-13 |
Family
ID=65024141
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020536766A Active JP7378401B2 (ja) | 2018-01-02 | 2018-12-21 | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
| JP2023187032A Withdrawn JP2024012452A (ja) | 2018-01-02 | 2023-10-31 | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
| JP2025060460A Pending JP2025106349A (ja) | 2018-01-02 | 2025-04-01 | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023187032A Withdrawn JP2024012452A (ja) | 2018-01-02 | 2023-10-31 | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
| JP2025060460A Pending JP2025106349A (ja) | 2018-01-02 | 2025-04-01 | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
Country Status (27)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7378401B2 (ja) * | 2018-01-02 | 2023-11-13 | サイネクシス,インコーポレーテッド | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| US7718189B2 (en) * | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
| NZ589967A (en) * | 2004-01-14 | 2012-07-27 | Gilead Sciences Inc | Lipid-based dispersions useful for drug delivery |
| ES2402659T3 (es) | 2006-04-03 | 2013-05-07 | Merck Sharp & Dohme Corp. | Derivados de enfumafungina como agentes antifúngicos |
| CA2700530C (en) * | 2007-09-28 | 2014-12-09 | Merck Sharp & Dohme Corp. | Antifungal agents |
| US8226965B2 (en) * | 2008-04-25 | 2012-07-24 | Nanobio Corporation | Methods of treating fungal, yeast and mold infections |
| JP2011529038A (ja) * | 2008-07-23 | 2011-12-01 | ターゲッティド デリバリー テクノロジーズ リミテッド | 真菌感染症の処置のための局所抗真菌製剤の投与方法 |
| WO2010019204A1 (en) * | 2008-08-12 | 2010-02-18 | Merck Sharp & Dohme Corp. | Antifungal agents |
| PE20120923A1 (es) * | 2009-03-30 | 2012-08-27 | Eisai Randd Man Co Ltd | Composiciones farmaceuticas comprendiendo liposomas que contiene eribulina o una sal del mismo |
| PT3247711T (pt) * | 2015-01-19 | 2022-05-16 | Scynexis Inc | Novos sais e polimorfos de scy-078 |
| JP7378401B2 (ja) * | 2018-01-02 | 2023-11-13 | サイネクシス,インコーポレーテッド | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
-
2018
- 2018-12-21 JP JP2020536766A patent/JP7378401B2/ja active Active
- 2018-12-21 SI SI201830746T patent/SI3735226T1/sl unknown
- 2018-12-21 CN CN202310046755.4A patent/CN115998684A/zh active Pending
- 2018-12-21 SG SG11202006313WA patent/SG11202006313WA/en unknown
- 2018-12-21 HU HUE18834263A patent/HUE060400T2/hu unknown
- 2018-12-21 SM SM20220427T patent/SMT202200427T1/it unknown
- 2018-12-21 US US16/958,691 patent/US20200338002A1/en not_active Abandoned
- 2018-12-21 EP EP22187779.8A patent/EP4137123A1/en active Pending
- 2018-12-21 AU AU2018399599A patent/AU2018399599B2/en active Active
- 2018-12-21 IL IL275758A patent/IL275758B2/en unknown
- 2018-12-21 HR HRP20221295TT patent/HRP20221295T1/hr unknown
- 2018-12-21 IL IL318793A patent/IL318793A/en unknown
- 2018-12-21 RS RS20220981A patent/RS63687B1/sr unknown
- 2018-12-21 EP EP18834263.8A patent/EP3735226B1/en active Active
- 2018-12-21 PT PT188342638T patent/PT3735226T/pt unknown
- 2018-12-21 PL PL18834263.8T patent/PL3735226T3/pl unknown
- 2018-12-21 DK DK18834263.8T patent/DK3735226T3/da active
- 2018-12-21 CN CN201880087851.0A patent/CN111655237B/zh active Active
- 2018-12-21 CA CA3087176A patent/CA3087176A1/en active Pending
- 2018-12-21 ES ES18834263T patent/ES2927051T3/es active Active
- 2018-12-21 MA MA051514A patent/MA51514A/fr unknown
- 2018-12-21 WO PCT/US2018/067216 patent/WO2019135954A1/en not_active Ceased
- 2018-12-21 LT LTEPPCT/US2018/067216T patent/LT3735226T/lt unknown
- 2018-12-21 KR KR1020207022062A patent/KR102694692B1/ko active Active
- 2018-12-21 EA EA202091626A patent/EA202091626A1/ru unknown
- 2018-12-21 UA UAA202004935A patent/UA126096C2/uk unknown
- 2018-12-21 MD MDE20201148T patent/MD3735226T2/ro unknown
- 2018-12-21 MX MX2020006992A patent/MX2020006992A/es unknown
- 2018-12-27 TW TW107147395A patent/TWI857944B/zh active
- 2018-12-27 TW TW112144149A patent/TWI862280B/zh active
-
2020
- 2020-06-30 SA SA520412362A patent/SA520412362B1/ar unknown
-
2022
- 2022-10-04 US US17/960,076 patent/US20230277455A1/en not_active Abandoned
-
2023
- 2023-10-31 JP JP2023187032A patent/JP2024012452A/ja not_active Withdrawn
-
2024
- 2024-03-18 US US18/608,350 patent/US20250082574A1/en not_active Abandoned
-
2025
- 2025-04-01 JP JP2025060460A patent/JP2025106349A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1998033481A1 (en) | Lipid complexes and liposomes of highly insoluble platinum complexes | |
| JP5735724B2 (ja) | 腹腔内投与される脂質ベースの白金化合物製剤を用いた、癌の治療方法 | |
| JP4950890B2 (ja) | 動物に対する鉄の送達 | |
| JP2025106349A (ja) | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 | |
| US20190343763A1 (en) | Methods of treating upper tract urothelial carcinomas | |
| JPH07501825A (ja) | 高められた抗真菌活性を有するアンフォテリシンb組成物 | |
| JP2019525922A (ja) | 癌を治療するための方法および組成物 | |
| AU2022393147A1 (en) | Formulated and/or co-formulated nanocarriers compositions containing immunogenic cell death (icd) inducing prodrugs useful in the treatment of cancer and methods thereof | |
| JP2022532734A5 (cg-RX-API-DMAC7.html) | ||
| NZ765771B2 (en) | Injectable compositions of triterpenoid antifungals encapsulated in liposomes | |
| JP2022519500A5 (cg-RX-API-DMAC7.html) | ||
| JP7606633B2 (ja) | 医薬組成物及びアプレピタント注射液並びに凍結乾燥粉末注射剤 | |
| JP2013534523A (ja) | 溶解度が向上した難溶性トリサイクリック誘導体の薬学的組成物 | |
| US20150056269A1 (en) | Liposome comprising at least one cholesterol derivative | |
| HK40036677A (en) | Injectable compositions of triterpenoid antifungals encapsulated in liposomes | |
| CN116807975A (zh) | 一种具有多室脂质体结构的药物载体制备方法 | |
| HK40036677B (en) | Injectable compositions of triterpenoid antifungals encapsulated in liposomes | |
| HK40090116A (en) | Injectable compositions of triterpenoid antifungals encapsulated in liposomes | |
| JP2022523212A5 (cg-RX-API-DMAC7.html) | ||
| HK1194981A (en) | Liposome comprising at least one cholesterol derivative |